Pharmacodynamics of Fluconazole in a Murine Model of Systemic Candidiasis
In this study we defined the pharmacodynamic parameter that optimizes outcome in deep-seated Candida albicans infections treated with fluconazole. Using a murine model of systemic candidiasis, we conducted single-dose dose-ranging studies with fluconazole to determine the dosage of this drug that re...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1998
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9593135/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.5.1105 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
